Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-FR Version v7-FR
Language French French
Date Updated 2022-02-08 2020-11-25
Drug Identification Number 02284294 02284294
Brand name APO-OXCARBAZEPINE APO-OXCARBAZEPINE
Common or Proper name OXCARBAZEPINE OXCARBAZEPINE
Company Name APOTEX INC APOTEX INC
Ingredients OXCARBAZEPINE OXCARBAZEPINE
Strength(s) 150MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N03AF N03AF
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2020-06-16 2020-06-16
Estimated end date 2022-03-31 2021-07-30
Actual end date 2022-02-08
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Allocating the limited remaining inventory
Health Canada comments